OPRX
OptimizeRx Corp

1,127
Mkt Cap
$204.49M
Volume
219,652.00
52W High
$22.25
52W Low
$3.99
PE Ratio
-4,161.54
OPRX Fundamentals
Price
$10.82
Prev Close
$10.97
Open
$11.01
50D MA
$13.28
Beta
1.59
Avg. Volume
255,390.32
EPS (Annual)
-$1.10
P/B
1.65
Rev/Employee
$714,162.79
Loading...
Loading...
News
all
press releases
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of OptimizeRx Corp. (NASDAQ:OPRX - Get Free Report) have been given an average rating of "Moderate Buy" by the nine ratings firms that are presently covering the firm, MarketBeat.com reports...
MarketBeat·17d ago
News Placeholder
More News
News Placeholder
Insider Selling: OptimizeRx (NASDAQ:OPRX) Insider Sells 1,388 Shares of Stock
OptimizeRx Corp. (NASDAQ:OPRX - Get Free Report) insider Edward Stelmakh sold 1,388 shares of the firm's stock in a transaction that occurred on Friday, December 19th. The stock was sold at an...
MarketBeat·1mo ago
News Placeholder
OptimizeRx (NASDAQ:OPRX) Insider Sells $18,751.88 in Stock
OptimizeRx Corp. (NASDAQ:OPRX - Get Free Report) insider Edward Stelmakh sold 1,388 shares of the business's stock in a transaction dated Friday, December 19th. The stock was sold at an average price...
MarketBeat·1mo ago
News Placeholder
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
OptimizeRx Corp. (NASDAQ:OPRX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the firm, MarketBeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
OptimizeRx (NASDAQ:OPRX) Cut to "Hold" at Zacks Research
Zacks Research lowered shares of OptimizeRx from a "strong-buy" rating to a "hold" rating in a report on Monday...
MarketBeat·1mo ago
News Placeholder
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to "Strong-Buy"
Wall Street Zen raised OptimizeRx from a "buy" rating to a "strong-buy" rating in a research note on Sunday...
MarketBeat·2mo ago
News Placeholder
OptimizeRx (NASDAQ:OPRX) Cut to "Buy" at Wall Street Zen
Wall Street Zen downgraded OptimizeRx from a "strong-buy" rating to a "buy" rating in a research report on Saturday...
MarketBeat·2mo ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX
Connor Clark & Lunn Investment Management Ltd. bought a new stake in OptimizeRx Corp. (NASDAQ:OPRX - Free Report) in the second quarter, according to its most recent filing with the Securities...
MarketBeat·2mo ago
News Placeholder
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX
P.A.W. Capital Corp purchased a new position in OptimizeRx Corp. (NASDAQ:OPRX - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·2mo ago
News Placeholder
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
ROKU, AVPT, ETOR, NRIM and OPRX have been added to the Zacks Rank #1 (Strong Buy) List on November 17, 2025.
Zacks·2mo ago
<
1
2
...
>

Latest OPRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.